Good afternoon,
please find below the latest CONTRACT vacancy for you to review;
Title: SAS Programmer - Phase I-IV Clinical Trials
Role: Essential, 2-4 years minimum SAS programming within the Pharmaceutical
/ CRO industries, SAS/base, SAS/macro, SAS/graph & excellent reporting
experience. Desirable, an understanding of statistics. Working for this
major client in various study teams, you main duties will be to program high
quality tables, listings & summaries. INTERVIEW TIMES AWAIT.
Start Date: ASAP, but January 2005 is feasible
Contract Length: 6 months
Location: Europe
Rate: Dependant on experience
If you are interested in the this role, please contact me as soon as
possible. If this role is not suitable OR you are not available, please feel
free to pass my details forward to a colleague etc. Maybe someone that does
not subscribe to this list but would be interested to hear more....
Regards
James Carrera
European Contracts Manager
Pharmaceutical, Healthcare & CRO division.
1st IT People
Tel: +44 (0) 207 940 3900
Fax: +44 (0) 207 886 8161
mailto:[log in to unmask]
www.1st-itpeople.com
Offices in UK, Switzerland, The Netherlands & Hong Kong
This email is confidential and intended solely for the use of the individual
to whom it is addressed. Any views or opinions presented are solely those of
the author and do not represent those of the company from which the email
was sent. If you are not the intended recipient, be advised that you have
received this e-mail in error and that any use, dissemination forwarding,
printing or copying of this e-mail is strictly prohibited. While every
effort has been made to scan this e-mail, we can not accept any
responsibility for loss of business or damage caused arising from this
e-mail.
This email is confidential and intended solely for the use of the
individual to whom it is addressed. Any views or opinions presented are
solely those of the author and do not represent those of the company from
which the email was sent. If you are not the intended recipient, be advised
that you have received this e-mail in error and that any use, dissemination
forwarding, printing or copying of this e-mail is strictly prohibited.
While every effort has been made to scan this e-mail, we can not accept any
responsibility for loss of business or damage caused arising from this
e-mail.
|